202 related articles for article (PubMed ID: 35945009)
41. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
Sato T; Nihei R; Sora D; Nishio Y; Takeuchi M
Front Immunol; 2022; 13():967972. PubMed ID: 36248859
[TBL] [Abstract][Full Text] [Related]
42. Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Dulovic A; Strengert M; Ramos GM; Becker M; Griesbaum J; Junker D; Lürken K; Beigel A; Wrenger E; Lonnemann G; Cossmann A; Stankov MV; Dopfer-Jablonka A; Kaiser PD; Traenkle B; Rothbauer U; Krause G; Schneiderhan-Marra N; Behrens GMN
Emerg Infect Dis; 2022 Apr; 28(4):743-750. PubMed ID: 35203113
[TBL] [Abstract][Full Text] [Related]
43. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
[TBL] [Abstract][Full Text] [Related]
44. Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases.
Raccampo L; Sembronio S; Tel A; Cacitti V; Robiony M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):e54-e57. PubMed ID: 35851250
[TBL] [Abstract][Full Text] [Related]
45. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia.
Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE
Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485
[TBL] [Abstract][Full Text] [Related]
46. Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review.
Chahed F; Ben Fadhel N; Ben Romdhane H; Youssef M; Ben Hammouda S; Chaabane A; Aouam K; Ben Fredj N
Br J Clin Pharmacol; 2023 Feb; 89(2):536-540. PubMed ID: 35434826
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
Rose C; Apgar R; Green M
J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159
[TBL] [Abstract][Full Text] [Related]
48. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
Jalkanen P; Kolehmainen P; Haveri A; Huttunen M; Laine L; Österlund P; Tähtinen PA; Ivaska L; Maljanen S; Reinholm A; Belik M; Smura T; Häkkinen HK; Ortamo E; Kantele A; Julkunen I; Lempainen J; Kakkola L
Microbiol Spectr; 2022 Apr; 10(2):e0225221. PubMed ID: 35262410
[TBL] [Abstract][Full Text] [Related]
49. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.
Sagy I; Zeller L; Raviv Y; Porges T; Bieber A; Abu-Shakra M
Rheumatol Int; 2022 Dec; 42(12):2261-2266. PubMed ID: 36098769
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological Characteristics of Autoimmune-Like Hepatitis Induced by COVID-19 mRNA Vaccine (Pfizer-BioNTech, BNT162b2): A Case Report and Literature Review.
Kim JH; Chae HB; Woo S; Song MS; Kim HJ; Woo CG
Int J Surg Pathol; 2023 Sep; 31(6):1156-1162. PubMed ID: 37272061
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine.
Luo A; Oakley A
Australas J Dermatol; 2022 Aug; 63(3):e247-e250. PubMed ID: 35607272
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
Kang SH; Kim MY; Cho MY; Baik SK
J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
[TBL] [Abstract][Full Text] [Related]
53. The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Fiorino F; Ciabattini A; Sicuranza A; Pastore G; Santoni A; Simoncelli M; Polvere J; Galimberti S; Baratè C; Sammartano V; Montagnani F; Bocchia M; Medaglini D
Front Immunol; 2022; 13():1017863. PubMed ID: 36248803
[TBL] [Abstract][Full Text] [Related]
54. An Unusual Presentation Of Steven-Johnson Syndrome After Bnt162b2 Covid-19 Vaccination.
Patel R; Lu V
J Ayub Med Coll Abbottabad; 2023; 35(1):180-181. PubMed ID: 36849405
[TBL] [Abstract][Full Text] [Related]
55. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report.
Takeyama R; Fukuda K; Kouzaki Y; Koga T; Hayashi S; Ohtani H; Inoue T
Acta Neurochir (Wien); 2022 Feb; 164(2):543-547. PubMed ID: 34783899
[TBL] [Abstract][Full Text] [Related]
56. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
Abdel-Qader DH; Abdel-Qader H; Silverthorne J; Kongkaew C; Al Meslamani AZ; Hayajneh W; Ata OMA; Shnaigat W; AbuRuz S; Al Nsour M; Alhariri A; Shnewer K; Da'ssan M; Obeidat NM; Nusair KE; Jalamdeh MS; Hawari F; Khader K; Hakim T; Hammad FA; Al Qudah M; Asad M
Clin Drug Investig; 2022 Oct; 42(10):813-827. PubMed ID: 35999428
[TBL] [Abstract][Full Text] [Related]
57. High degree atrio-ventricular block following COVID-19 vaccination.
Nashashibi S; Priesler O; Levinger U; Habib G
Isr Med Assoc J; 2022 Oct; 24(10):627-628. PubMed ID: 36309855
[TBL] [Abstract][Full Text] [Related]
58. Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine.
Sapsford S; Wood B
N Z Med J; 2022 Oct; 135(1564):72-76. PubMed ID: 36302245
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
60. Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.
Cassart EM; Vilas DR; Abe R; Cavanilles-Walker JM
J Am Acad Orthop Surg Glob Res Rev; 2023 Mar; 7(3):. PubMed ID: 36893168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
